Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
We are confident that Waveform AI has the potential to significantly enhance the healthcare landscape, and we are developing a platform designed to equip clinicians with essential information and support throughout the entire care continuum. Transforming healthcare truly requires collective effort, and to play our part in advancing the industry, we are publishing peer-reviewed research on AI to illustrate its benefits at every stage of the patient care experience. Our platform aims to assist providers in identifying individuals at high risk for sleep apnea by leveraging data from electronic medical records, waveforms, wearables, and various other sources, facilitating timely referrals for diagnosis. By utilizing this data, we can aid healthcare providers in pinpointing the most critical patients among the vast undiagnosed population, categorizing them based on their risk for adverse outcomes and potential healthcare costs. Additionally, we strive to streamline the diagnostic process for clinicians, enabling them to treat more patients efficiently and effectively by improving the overall quality and speed of sleep apnea diagnoses. In doing so, we hope to foster a healthier future for all patients.
Description
Specialty and rare diseases often encompass patient populations that are not clearly defined, including individuals who remain undiagnosed or face misdiagnoses, along with healthcare providers who may lack knowledge about these conditions and their various manifestations, resulting in treatment pathways that are poorly understood. IPM.ai operates as an Insights-as-a-Service (IaaS) firm, dedicated to empowering leading life sciences organizations to gain deeper insights into patient care and enhance the quality of life for those affected through the development, clinical research, and commercialization of therapeutic solutions. By predicting market size, analyzing the competitive landscape, and estimating potential return on investment, companies can optimize their commercialization strategies. Additionally, the platform identifies undiagnosed and misdiagnosed individuals who could benefit from early disease interception and therapeutic measures. It employs statistical models to gauge the prevalence of specific diseases within certain patient populations at any given moment. Furthermore, IPM.ai helps pinpoint physicians who are adept at diagnosing and treating these ideal patients, while also influencing other healthcare providers to enhance overall patient outcomes. This comprehensive approach ultimately aims to bridge the gap in understanding and addressing the needs of those with rare diseases.
API Access
Has API
API Access
Has API
Integrations
No details available.
Integrations
No details available.
Pricing Details
$8.25 per month
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
EnsoData
Country
United States
Website
www.ensodata.com/technology/
Vendor Details
Company Name
IPM.ai
Country
United States
Website
www.ipm.ai/platform